Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.

BACKGROUND: Merozoite surface protein (MSP) 5 is a candidate antigen for a malaria vaccine. In cross-sectional and longitudinal studies, we measured MSP5 antibody responses in Papuans with acute Plasmodium falciparum malaria, Plasmodium vivax malaria, and mixed P. falciparum and P. vivax malaria an...

Full description

Bibliographic Details
Main Authors:	Woodberry, T, Minigo, G, Piera, K, Hanley, J, de Silva, H, Salwati, E, Kenangalem, E, Tjitra, E, Coppel, R, Price, R, Anstey, N, Plebanski, M
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
by: Salwati, E, et al.
Published: (2011)

Acute malaria induced antibodies against merozoite surface protein 5: frequent induction and analysis of cross-reactivity between P-falciparum and P-vivax.
by: Woodberry, T, et al.
Published: (2008)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
by: Price, R, et al.
Published: (2010)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.
by: Kho, S, et al.
Published: (2015)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
by: Karyana, M, et al.
Published: (2008)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.
by: Minigo, G, et al.
Published: (2009)

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
by: Russell, B, et al.
Published: (2008)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant <it>Plasmodium vivax </it>and <it>Plasmodium falciparum</it>
by: Okoseray Maurits J, et al.
Published: (2008-08-01)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
by: Ratcliff, A, et al.
Published: (2007)

Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming.
by: Lee, E, et al.
Published: (2006)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
by: Lampah, D, et al.
Published: (2011)

Plasmodium falciparum activates CD16+ dendritic cells to produce TNF and IL-10 in subpatent malaria
by: Loughland, JR, et al.
Published: (2018)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
by: Price, R, et al.
Published: (2007)

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2012)

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
by: Douglas, A, et al.
Published: (2014)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, E, et al.
Published: (2017)

Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.
by: Woodberry, T, et al.
Published: (2009)

The acquisition and maintenance of antibodies against Plasmodium falciparum merozoite antigens in childhood
by: Mugyenyi, C, et al.
Published: (2007)

Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3
by: Bitencourt, A, et al.
Published: (2013)

Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum
by: McLean, A, et al.
Published: (2017)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

The antibody response to <it>Plasmodium falciparum </it>Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes
by: Black Casilda G, et al.
Published: (2011-09-01)

Limitations of microscopy to differentiate <it>Plasmodium</it> species in a region co-endemic for <it>Plasmodium falciparum</it>, <it>Plasmodium vivax</it> and <it>Plasmodium knowlesi</it>
by: Barber Bridget E, et al.
Published: (2013-01-01)

Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection
by: Loughland, JR, et al.
Published: (2020)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
by: Amanda R Bitencourt, et al.
Published: (2013-01-01)

Complement activation by merozoite antigens of Plasmodium falciparum.
by: Jackson C Korir, et al.
Published: (2014-01-01)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
by: Suwanarusk, R, et al.
Published: (2007)